FDA Inspection 1277234 — Saol Therapeutics Inc
The FDA completed an inspection of Saol Therapeutics Inc on August 1, 2025 in Roswell, GA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Devices.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 1, 2025
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Roswell, GA (United States)